In the bio-tech market, the Nasdaq (NDAQ) continues to exhibit strong momentum with an increase in shares purchased by Foster Victor Wealth Advisors LLC and Strategic Investment Advisors MI, contributing significantly to positive market sentiment. Although Nasdaq's share prices dropped over 5.8% following strong Q4 earnings, the Short Interest Surges reveal a substantial inflow of 1.2% quarterly dividends. Financial analysts like UBS Group and JPMorgan Chase & Co. anticipate a rise in Nasdaq's stock price. Reporting insubstantial decreases in the stock position, entities such as Robeco Institutional Asset Management B.V. and Manning & Napier Advisors LLC remain optimistic. Encouragement finds additional grounding in the solid fourth-quarter profits where Nasdaq showed a 10% Y/Y increase in revenues. Earnings have been consistently surpassing the estimates supported by higher revenues. Continuing the bullish trend, even the short interest positions and average daily volume dropped, it continues to be an attractive stock for investment.
Nasdaq NDAQ News Analytics from Wed, 29 May 2024 07:00:00 GMT to Sat, 01 Feb 2025 08:33:38 GMT -
Rating 8
- Innovation 7
- Information 7
- Rumor 2
